Cartesian Therapeutics, Inc. 8-K

What Happened
Cartesian Therapeutics, Inc. announced its financial results for the year ended December 31, 2025 in a press release issued and furnished with a Form 8-K on March 9, 2026. The company disclosed the announcement under Item 2.02 (Results of Operations and Financial Condition) of the Form 8-K; the full press release is included as Exhibit 99.1 to the filing.

Key Details

• Date of announcement: March 9, 2026.
• Reporting period: year ended December 31, 2025.
• Press release is furnished as Exhibit 99.1 to the Form 8-K.
• Interactive XBRL cover page (Exhibit 104) was included with the filing.

Why It Matters
This 8-K signals that Cartesian has issued its latest earnings and financial condition information—key data that can affect investor assessment of the company’s revenue, cash position, R&D spending, and runway. Retail investors should read the Exhibit 99.1 press release (and any subsequent 10-K or earnings call materials) to see the specific figures for revenue, net income or loss, cash and equivalents, and management commentary before making investment decisions.